Palumbo Wealth Management LLC Heron Therapeutics, Inc. Transaction History
Palumbo Wealth Management LLC
- $308 Million
- Q2 2025
A detailed history of Palumbo Wealth Management LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Palumbo Wealth Management LLC holds 132,433 shares of HRTX stock, worth $251,622. This represents 0.09% of its overall portfolio holdings.
Number of Shares
132,433
Previous 124,103
6.71%
Holding current value
$251,622
Previous $273,000
0.37%
% of portfolio
0.09%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding HRTX
# of Institutions
183Shares Held
125MCall Options Held
847KPut Options Held
47.7K-
Rubric Capital Management LP New York, NY26.7MShares$50.8 Million1.68% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$15.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.23MShares$15.6 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA7.85MShares$14.9 Million0.03% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$13.3 Million26.51% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $226M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...